<![CDATA[PDC*line Pharma 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=34395>Sat, 07 Mar 2026 18:21:42 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[PDC*line Pharma Presents Primary Clinical Results From Phase I/II Trial on PDC*lung01 Cancer Vaccine at ESMO-IO 2024]]>https://www.newswire.co.kr/newsRead.php?no=1002812Fri, 13 Dec 2024 11:55:00 +0900<![CDATA[PDC*라인 파마, ESMO-IO 2024에서 ‘PDC*lung01’ 항암 백신 임상 1/2상 결과 발표]]>https://www.newswire.co.kr/newsRead.php?no=1002814Fri, 13 Dec 2024 11:55:00 +0900<![CDATA[AACR 2024: PDC*line Pharma Presents Interim Clinical Results From Last Cohort of Patients in Phase I/II Trial with PDC*lung01 Cancer Vaccine]]>https://www.newswire.co.kr/newsRead.php?no=987513Tue, 09 Apr 2024 12:05:00 +0900<![CDATA[PDC*라인 파마, AACR 2024서 ‘PDC*lung01’ 항암 백신 임상 1/2상 중간 결과 발표]]>https://www.newswire.co.kr/newsRead.php?no=987515Tue, 09 Apr 2024 12:05:00 +0900<![CDATA[PDC*line Pharma and Partners Receive €8.1M From Walloon Region and Wallonia Health Cluster BioWin for Personalized Therapeutic Vaccine Project]]>https://www.newswire.co.kr/newsRead.php?no=982846Thu, 18 Jan 2024 15:15:00 +0900<![CDATA[PDC*라인 파마, 파트너사와 810만유로 투자 유치… 벨기에 왈룬 지역 및 왈로니아 헬스 클러스터 바이오윈 투자로 맞춤형 치료 백신 프로젝트 개시]]>https://www.newswire.co.kr/newsRead.php?no=982849Thu, 18 Jan 2024 15:15:00 +0900<![CDATA[PDC*line Pharma Completes Enrolment of Four Cohorts of Patients in PDC-LUNG-101 Phase I/II Clinical Trial]]>https://www.newswire.co.kr/newsRead.php?no=980440Thu, 07 Dec 2023 11:20:00 +0900<![CDATA[PDC*라인 파마, PDC-LUNG-101 임상 1/2상 환자 등록 완료]]>https://www.newswire.co.kr/newsRead.php?no=980441Thu, 07 Dec 2023 11:20:00 +0900<![CDATA[PDC*line Pharma Presents First Immunological Results From Phase I/II Trial With PDC*lung01 at ESMO-IO 2022]]>https://www.newswire.co.kr/newsRead.php?no=957518Fri, 09 Dec 2022 09:00:00 +0900<![CDATA[PDC*라인 파마, ‘ESMO-IO 2022’서 PDC*lung01에 대한 임상 1/2상 첫 면역학적 결과 발표]]>https://www.newswire.co.kr/newsRead.php?no=957519Fri, 09 Dec 2022 09:00:00 +0900<![CDATA[PDC*line Pharma Presents First Clinical Results From Phase I/II trial With PDC*lung01 at ESMO 2022]]>https://www.newswire.co.kr/newsRead.php?no=951084Tue, 13 Sep 2022 11:15:00 +0900<![CDATA[PDC*라인 파마, ’ESMO 2022’서 off-the-shelf 항암 백신 PDC*lung01 임상 1/2상 1차 결과 발표]]>https://www.newswire.co.kr/newsRead.php?no=951085Tue, 13 Sep 2022 11:15:00 +0900<![CDATA[PDC*line Pharma Raises €17.5 Million in Series B2 Financing Round]]>https://www.newswire.co.kr/newsRead.php?no=935739Mon, 06 Dec 2021 17:00:00 +0900<![CDATA[PDC*라인 파마, 시리즈 B2 투자 라운드로 1750만유로 조달]]>https://www.newswire.co.kr/newsRead.php?no=935740Mon, 06 Dec 2021 17:00:00 +0900<![CDATA[PDC*line Pharma Announces the Administration of a First Patient With Its Therapeutic Cancer Vaccine Candidate (PDC*lung01) Targeting Non-small Cell Lung Cancer]]>https://www.newswire.co.kr/newsRead.php?no=901983Tue, 03 Mar 2020 16:00:00 +0900<![CDATA[PDC*라인 파마, 비소세포폐암 치료를 위한 항암 백신 후보물질 (PDC*lung01) 최초 환자 투여 발표]]>https://www.newswire.co.kr/newsRead.php?no=901984Tue, 03 Mar 2020 16:00:00 +0900<![CDATA[PDC*line Pharma Raises €20 Million in Series B Financing Round]]>https://www.newswire.co.kr/newsRead.php?no=900254Wed, 22 Jan 2020 16:00:00 +0900<![CDATA[PDC 라인 파마, 시리즈 B 투자 라운드로 2000만유로 유치]]>https://www.newswire.co.kr/newsRead.php?no=900258Wed, 22 Jan 2020 16:00:00 +0900